Arax Advisory Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1K Buy
+800
New +$43.4K ﹤0.01% 3585

Other funds holding BSX

Arax Advisory Partners's BSX Position: Q2 2026 in Review

Arax Advisory Partners increased its Boston Scientific (BSX) stake by 333% in Q2 2026, buying an estimated $3.23M and bringing the position to 77,337 shares worth $3.3M. The position accounts for 0.02% of the portfolio, ranked #623.

Arax Advisory Partners first reported a position in BSX in Q1 2018 and has held it in 12 quarters since. The position peaked at $3.76M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Arax Advisory Partners held 77,337 shares of Boston Scientific worth $3.3M as of Q2 2026.
  • Arax Advisory Partners bought 59,460 Boston Scientific shares in Q2 2026, an estimated $3.23M.
  • Boston Scientific made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #623 holding.
  • Arax Advisory Partners first reported a position in Boston Scientific in Q1 2018 and has held it in 12 quarters since.
  • Arax Advisory Partners's Boston Scientific position peaked at $3.76M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.